Your browser doesn't support javascript.
loading
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei.
Dillon, Magnus T; Barker, Holly E; Pedersen, Malin; Hafsi, Hind; Bhide, Shreerang A; Newbold, Kate L; Nutting, Christopher M; McLaughlin, Martin; Harrington, Kevin J.
Afiliação
  • Dillon MT; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Barker HE; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Pedersen M; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Hafsi H; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Bhide SA; The Royal Marsden Hospital, London, UK.
  • Newbold KL; The Royal Marsden Hospital, London, UK.
  • Nutting CM; The Royal Marsden Hospital, London, UK.
  • McLaughlin M; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Harrington KJ; Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Mol Cancer Ther ; 16(1): 25-34, 2017 01.
Article em En | MEDLINE | ID: mdl-28062704

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Radiossensibilizantes / Sulfóxidos / Micronúcleos com Defeito Cromossômico / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Radiossensibilizantes / Sulfóxidos / Micronúcleos com Defeito Cromossômico / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido